國際藥物經(jīng)濟(jì)學(xué)和結(jié)果研究學(xué)會(ISPOR)的官方期刊。《健康價(jià)值》是一份多學(xué)科同行評議的期刊，報(bào)告了對包括藥物、生物制劑、設(shè)備、程序和其他衛(wèi)生保健干預(yù)措施在內(nèi)的醫(yī)療技術(shù)的評估。該雜志為傳播衛(wèi)生經(jīng)濟(jì)學(xué)和成果研究方法和發(fā)現(xiàn)提供了一個(gè)科學(xué)論壇，進(jìn)一步推進(jìn)了ISPOR的愿景，即“社會明智、公平和有效地分配稀缺的衛(wèi)生保健資源”。《健康價(jià)值》也是討論與健康經(jīng)濟(jì)學(xué)有關(guān)的健康政策問題和與所有醫(yī)療技術(shù)有關(guān)的結(jié)果研究的宣傳平臺。主題包括成本效益/成本效益/成本效益分析、健康用途/偏好、與健康有關(guān)的生活/健康狀況研究質(zhì)量、醫(yī)療實(shí)踐指南、疾病管理、研究設(shè)計(jì)(展望、回顧和建模)以及對現(xiàn)有文獻(xiàn)的批判性評論。

The Official Journal of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Value in Health is a multidisciplinary peer-reviewed journal reporting on evaluations of medical technologies including pharmaceuticals, biologics, devices, procedures, and other health care interventions. The Journal provides a scientific forum for communicating health economics and outcomes research methods and findings, furthering ISPOR''s vision that "society allocate scarce health care resources wisely, fairly, and efficiently." Value in Health is also a sounding board for the discussion of health policy issues related to health economics and outcomes studies associated with all medical technologies. Topics include cost effectiveness/cost utility/cost benefit analysis, health utilities/preferences, health-related quality of life/health status research, medical practice guidelines, disease management, study designs (prospective, retrospective, and modeling), and critical reviews of existing literature.